Jian Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Ma has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Liang Liu
Department of Cardiology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
3 shared publications- Chengxing Shen
Department of Cardiology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
2 shared publications Guoqing Wan
Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China
2 shared publicationsHong Shen
Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China
2 shared publicationsHongqi Li
Department of Geriatrics, The First Affiliated Hospital of University of science and technology of China, Hefei, 230017, China
2 shared publicationsJingrong Lin
Department of Hypertension, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1932236
Magnetocardiographic characteristics in patients with varying severity of obstructive sleep apnea syndrome
Background: Obstructive sleep apnea syndrome (OSAS) is an established risk factor for cardiovascular disease. Magnetocardiography (MCG) is an emerging non-invasive electrophysiological technique with potential value in cardiovascular assessment; however, its utility in evaluating OSAS severity remains unclear. This study aimed to characterize MCG features across different severities of OSAS and to evaluate their predictive performance for moderate-to-severe disease. Methods: This retrospective study enrolled OSAS patients between June 2023 and October 2024, all of whom underwent MCG examination. Patients were stratified by OSAS severity, and MCG parameters were compared between the normal-to-mild and moderate-to-severe groups. Baseline data, complete blood count, serum biochemical indicators, and MCG parameters were collected along with relevant clinical and laboratory data. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of moderate-to-severe OSAS, and receiver operating characteristic (ROC) curves were constructed to evaluate the predictive performance of each parameter and the combined model. Results: Group comparisons revealed significant differences in traditional OSAS severity risk factors (sex, body mass index, etc.). Diastolic function indicators, including E/A ratio and left atrial size, also showed marked differences between groups, with the moderate-to-severe subgroup exhibiting larger left atria and a higher proportion of E/A ratio values below 1. Univariate analysis identified 35 MCG parameters that differed between groups, while multivariate regression retained four independent predictors (htrt, tmdf, RS-didma, and qr_rela_dist_neg_mode). ROC analysis indicated that T-wave- and QRS-wave-related indices had moderate predictive value; a combined model incorporating htrt, tmdf, and RS-didma showed superior area under the curve compared to any single parameter. Conclusion: MCG parameters demonstrate distinct characteristics across OSAS severity levels and yield favorable predictive performance for moderate-to-severe OSAS, positioning MCG as a promising non-invasive tool for early diagnosis. The observed changes in diastolic function markers may suggest underlying coronary microcirculatory alterations in patients with moderate-to-severe OSAS. Rigorously designed prospective studies are warranted to validate MCG as a standardized diagnostic modality for OSAS-related coronary microcirculation disorder.
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1932236
Open AccessMagnetocardiographic characteristics in patients with varying severity of obstructive sleep apnea syndrome
Background: Obstructive sleep apnea syndrome (OSAS) is an established risk factor for cardiovascular disease. Magnetocardiography (MCG) is an emerging non-invasive electrophysiological technique with potential value in cardiovascular assessment; however, its utility in evaluating OSAS severity remains unclear. This study aimed to characterize MCG features across different severities of OSAS and to evaluate their predictive performance for moderate-to-severe disease. Methods: This retrospective study enrolled OSAS patients between June 2023 and October 2024, all of whom underwent MCG examination. Patients were stratified by OSAS severity, and MCG parameters were compared between the normal-to-mild and moderate-to-severe groups. Baseline data, complete blood count, serum biochemical indicators, and MCG parameters were collected along with relevant clinical and laboratory data. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of moderate-to-severe OSAS, and receiver operating characteristic (ROC) curves were constructed to evaluate the predictive performance of each parameter and the combined model. Results: Group comparisons revealed significant differences in traditional OSAS severity risk factors (sex, body mass index, etc.). Diastolic function indicators, including E/A ratio and left atrial size, also showed marked differences between groups, with the moderate-to-severe subgroup exhibiting larger left atria and a higher proportion of E/A ratio values below 1. Univariate analysis identified 35 MCG parameters that differed between groups, while multivariate regression retained four independent predictors (htrt, tmdf, RS-didma, and qr_rela_dist_neg_mode). ROC analysis indicated that T-wave- and QRS-wave-related indices had moderate predictive value; a combined model incorporating htrt, tmdf, and RS-didma showed superior area under the curve compared to any single parameter. Conclusion: MCG parameters demonstrate distinct characteristics across OSAS severity levels and yield favorable predictive performance for moderate-to-severe OSAS, positioning MCG as a promising non-invasive tool for early diagnosis. The observed changes in diastolic function markers may suggest underlying coronary microcirculatory alterations in patients with moderate-to-severe OSAS. Rigorously designed prospective studies are warranted to validate MCG as a standardized diagnostic modality for OSAS-related coronary microcirculation disorder.
- Open Access
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1897324
Incremental effect and risk association of obstructive coronary artery disease on microvascular myocardial ischemia in T2DM patients evaluated via CT myocardial perfusion
Objective: Microvascular myocardial ischemia (MMI) in patients with T2DM may be influenced by the presence of concomitant obstructive coronary artery disease (OCAD). Our investigation focused on assessing the impact of OCAD on MMI and delineating the prognostic relevance of MMI. Methods: This study included four groups: (1) control group without OCAD ( n = 125), (2) control group with OCAD ( n = 99); (3) T2DM patients without OCAD ( n = 100); (4) T2DM patients with OCAD ( n = 93). All patients received dynamic computed tomography myocardial perfusion imaging (CT–MPI) as well as coronary computed tomography angiography (CCTA). Univariate and multivariate linear regression analyses were performed to identify independent determinants of clinical characteristics and perfusion metrics related to MMI. Major adverse cardiovascular events (MACEs) were documented, and the prognostic significance of CT–MPI compared with clinical variables was assessed. Results: The myocardial blood flow (MBF) stepwise reduced from the control (OCAD−), T2DM (OCAD−), control (OCAD+) to T2DM (OCAD+) group ( p < 0.05). Independent associations were observed between global MBF and OCAD or T2DM (OCAD: p < 0.05, R 2 = 0.154; T2DM: β = −11.96, p < 0.001, R 2 = 0.101). A significant association was observed between OCAD and global MBF in the circumstance of T2DM (R 2 = 0.176). An independent association was observed between the global MBF and MACEs ( p < 0.05). Conclusion: Dynamic CT–MPI combined with CCTA demonstrated that the presence of OCAD in T2DM patients is associated with a greater occurrence of MMI. MBF emerged as a robust predictor of cardiovascular outcomes in this population.
- 22 September 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1897324
Open AccessIncremental effect and risk association of obstructive coronary artery disease on microvascular myocardial ischemia in T2DM patients evaluated via CT myocardial perfusion
Objective: Microvascular myocardial ischemia (MMI) in patients with T2DM may be influenced by the presence of concomitant obstructive coronary artery disease (OCAD). Our investigation focused on assessing the impact of OCAD on MMI and delineating the prognostic relevance of MMI. Methods: This study included four groups: (1) control group without OCAD ( n = 125), (2) control group with OCAD ( n = 99); (3) T2DM patients without OCAD ( n = 100); (4) T2DM patients with OCAD ( n = 93). All patients received dynamic computed tomography myocardial perfusion imaging (CT–MPI) as well as coronary computed tomography angiography (CCTA). Univariate and multivariate linear regression analyses were performed to identify independent determinants of clinical characteristics and perfusion metrics related to MMI. Major adverse cardiovascular events (MACEs) were documented, and the prognostic significance of CT–MPI compared with clinical variables was assessed. Results: The myocardial blood flow (MBF) stepwise reduced from the control (OCAD−), T2DM (OCAD−), control (OCAD+) to T2DM (OCAD+) group ( p < 0.05). Independent associations were observed between global MBF and OCAD or T2DM (OCAD: p < 0.05, R 2 = 0.154; T2DM: β = −11.96, p < 0.001, R 2 = 0.101). A significant association was observed between OCAD and global MBF in the circumstance of T2DM (R 2 = 0.176). An independent association was observed between the global MBF and MACEs ( p < 0.05). Conclusion: Dynamic CT–MPI combined with CCTA demonstrated that the presence of OCAD in T2DM patients is associated with a greater occurrence of MMI. MBF emerged as a robust predictor of cardiovascular outcomes in this population.
- 7 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 182, 116805
Exosomal miR-124 from M2 macrophages protects against hypertensive cardiac remodeling through suppression of Calpain-1
- 7 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 182, 116805
Exosomal miR-124 from M2 macrophages protects against hypertensive cardiac remodeling through suppression of Calpain-1
- 30 April 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (7) , 276
Transformer-Riemannian approach for MCG signal classification
- 30 April 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (7) , 276
Transformer-Riemannian approach for MCG signal classification
- 17 January 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 246, 196-208
Orientin alleviates severe inflammation via regulating macrophage glycolysis and immune function in sepsis
- 17 January 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 246, 196-208
Orientin alleviates severe inflammation via regulating macrophage glycolysis and immune function in sepsis
- 6 January 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (1) , 110
Edge-aware multi-head transformer for noise-robust full-field magnetocardiography signal modeling
- 6 January 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (1) , 110
Edge-aware multi-head transformer for noise-robust full-field magnetocardiography signal modeling
- 8 June 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 115033
Targeting notch1 with berbamine alleviates the inflammatory responses of macrophages in sepsis
- 8 June 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 115033
Targeting notch1 with berbamine alleviates the inflammatory responses of macrophages in sepsis
- Open Access
- 26 May 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-19
Macrophage Notch1 drives septic cardiac dysfunction by impairing mitophagy and promoting NLRP3 activation
Sepsis is a life-threatening condition with limited therapeutic options, characterized as excessive systemic inflammation and multiple organ failure. Macrophages play critical roles in sepsis pathogenesis. Although numerous studies support the critical role of Notch signaling in most inflammatory diseases, the function of Notch1 signaling in macrophages activation and its underlying molecular mechanism during sepsis has not been fully elucidated. We evaluated Notch1 expression in a lipopolysaccharide (LPS)-induced model of septic cardiac dysfunction. Using macrophage-specific Notch1 knockout mice (NOTCH1ΔMyelo) in conjunction with AAV-F4/80-mediated NICD1 overexpression, we investigated the impact of Notch1 on septic cardiac injury. LPS-stimulated bone marrow-derived macrophages (BMDMs) were analyzed by flow cytometry and ELISA to assess mitochondrial damage and inflammasome activation. Mitophagy flux and related protein levels were quantified, and a mitophagy inhibitor was applied to further delineate Notch1’s in vivo role. Downstream targets of Notch1 were identified and validated via ChIP-qPCR and luciferase reporter assays. Intraperitoneal injection of LPS markedly impaired cardiac function, increased macrophage infiltration, and elevated Notch1 expression compared with PBS-treated controls. Notch1 expression was inversely correlated with cardiac performance in LPS-treated mice. Notably, macrophage-specific deletion of Notch1 significantly improved cardiac function, whereas NICD1 overexpression worsened LPS-induced cardiac injury. NOTCH1ΔMyelo macrophages showed reduced mitochondrial damage and diminished activation of NLRP3-dependent caspase-1. Moreover, LPS induced mitophagy, an effect that was further enhanced by Notch1 knockout. Mechanistically, ChIP-seq and qPCR analyses revealed that NICD1 upregulates Mst1 transcription. Furthermore, overexpression of Mst1 counteracted the increased mitophagy in Notch1-deficient macrophages, resulting in elevated mitochondrial reactive oxygen species production, inflammatory cytokine secretion, and caspase-1 activation during prolonged LPS stimulation. Our study uncovers a novel role for Notch1 in exacerbating LPS-induced septic cardiac dysfunction by suppressing mitophagy in macrophages. These findings suggest that targeting Notch1 may offer a promising therapeutic strategy to mitigate sepsis-induced inflammation by restoring proper mitophagy.
- 26 May 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-19
Open AccessMacrophage Notch1 drives septic cardiac dysfunction by impairing mitophagy and promoting NLRP3 activation
Sepsis is a life-threatening condition with limited therapeutic options, characterized as excessive systemic inflammation and multiple organ failure. Macrophages play critical roles in sepsis pathogenesis. Although numerous studies support the critical role of Notch signaling in most inflammatory diseases, the function of Notch1 signaling in macrophages activation and its underlying molecular mechanism during sepsis has not been fully elucidated. We evaluated Notch1 expression in a lipopolysaccharide (LPS)-induced model of septic cardiac dysfunction. Using macrophage-specific Notch1 knockout mice (NOTCH1ΔMyelo) in conjunction with AAV-F4/80-mediated NICD1 overexpression, we investigated the impact of Notch1 on septic cardiac injury. LPS-stimulated bone marrow-derived macrophages (BMDMs) were analyzed by flow cytometry and ELISA to assess mitochondrial damage and inflammasome activation. Mitophagy flux and related protein levels were quantified, and a mitophagy inhibitor was applied to further delineate Notch1’s in vivo role. Downstream targets of Notch1 were identified and validated via ChIP-qPCR and luciferase reporter assays. Intraperitoneal injection of LPS markedly impaired cardiac function, increased macrophage infiltration, and elevated Notch1 expression compared with PBS-treated controls. Notch1 expression was inversely correlated with cardiac performance in LPS-treated mice. Notably, macrophage-specific deletion of Notch1 significantly improved cardiac function, whereas NICD1 overexpression worsened LPS-induced cardiac injury. NOTCH1ΔMyelo macrophages showed reduced mitochondrial damage and diminished activation of NLRP3-dependent caspase-1. Moreover, LPS induced mitophagy, an effect that was further enhanced by Notch1 knockout. Mechanistically, ChIP-seq and qPCR analyses revealed that NICD1 upregulates Mst1 transcription. Furthermore, overexpression of Mst1 counteracted the increased mitophagy in Notch1-deficient macrophages, resulting in elevated mitochondrial reactive oxygen species production, inflammatory cytokine secretion, and caspase-1 activation during prolonged LPS stimulation. Our study uncovers a novel role for Notch1 in exacerbating LPS-induced septic cardiac dysfunction by suppressing mitophagy in macrophages. These findings suggest that targeting Notch1 may offer a promising therapeutic strategy to mitigate sepsis-induced inflammation by restoring proper mitophagy.
- Top Cited PapersOpen Access
- 5 April 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (4) , 1-13
Nogo-B promotes angiogenesis and improves cardiac repair after myocardial infarction via activating Notch1 signaling
Nogo-B (Reticulon 4B) is reportedly a regulator of angiogenesis during the development and progression of cancer. However, whether Nogo-B regulates angiogenesis and post-myocardial infarction (MI) cardiac repair remains elusive. In the present study, we aimed to explore the role and underlying mechanisms of Nogo-B in cardiac repair during MI. We observed an increased expression level of Nogo-B in the heart of mouse MI models, as well as in isolated cardiac microvascular endothelial cells (CMECs). Moreover, Nogo-B was significantly upregulated in CMECs exposed to oxygen-glucose deprivation (OGD). Nogo-B overexpression in the endothelium via cardiotropic adeno-associated virus serotype 9 (AAV9) with the mouse endothelial-specific promoterTie2improved heart function, reduced scar size, and increased angiogenesis. RNA-seq data indicated that Notch signaling is a deregulated pathway in isolated CMECs along the border zone of the infarct with Nogo-B overexpression. Mechanistically, Nogo-B activated Notch1 signaling and upregulated Hes1 in the MI hearts. Inhibition of Notch signaling using a specific siRNA and γ-secretase inhibitor abolished the promotive effects of Nogo-B overexpression on network formation and migration of isolated cardiac microvascular endothelial cells (CMECs). Furthermore, endothelial Notch1 heterozygous deletion inhibited Nogo-B-induced cardioprotection and angiogenesis in the MI model. Collectively, this study demonstrates that Nogo-B is a positive regulator of angiogenesis by activating the Notch signaling pathway, suggesting that Nogo-B is a novel molecular target for ischemic disease.
- 5 April 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (4) , 1-13
Top Cited PapersOpen AccessNogo-B promotes angiogenesis and improves cardiac repair after myocardial infarction via activating Notch1 signaling
Nogo-B (Reticulon 4B) is reportedly a regulator of angiogenesis during the development and progression of cancer. However, whether Nogo-B regulates angiogenesis and post-myocardial infarction (MI) cardiac repair remains elusive. In the present study, we aimed to explore the role and underlying mechanisms of Nogo-B in cardiac repair during MI. We observed an increased expression level of Nogo-B in the heart of mouse MI models, as well as in isolated cardiac microvascular endothelial cells (CMECs). Moreover, Nogo-B was significantly upregulated in CMECs exposed to oxygen-glucose deprivation (OGD). Nogo-B overexpression in the endothelium via cardiotropic adeno-associated virus serotype 9 (AAV9) with the mouse endothelial-specific promoterTie2improved heart function, reduced scar size, and increased angiogenesis. RNA-seq data indicated that Notch signaling is a deregulated pathway in isolated CMECs along the border zone of the infarct with Nogo-B overexpression. Mechanistically, Nogo-B activated Notch1 signaling and upregulated Hes1 in the MI hearts. Inhibition of Notch signaling using a specific siRNA and γ-secretase inhibitor abolished the promotive effects of Nogo-B overexpression on network formation and migration of isolated cardiac microvascular endothelial cells (CMECs). Furthermore, endothelial Notch1 heterozygous deletion inhibited Nogo-B-induced cardioprotection and angiogenesis in the MI model. Collectively, this study demonstrates that Nogo-B is a positive regulator of angiogenesis by activating the Notch signaling pathway, suggesting that Nogo-B is a novel molecular target for ischemic disease.